Acknowledgement
This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF- 2020R1A2C1014798 and BB21+Project in 2021.
References
- Roehrborn CG. 2005. Benign prostatic hyperplasia: an overview. Rev. Urol. 7: S3.
- Coffey DS, Walsh PC. 1990. Clinical and experimental studies of benign prostatic hyperplasia. Urol. Clin. North Am. 17: 461-475. https://doi.org/10.1016/S0094-0143(21)00960-5
- Farnsworth WE. 1999. Estrogen in the etiopathogenesis of BPH. Prostate 41: 263-274. https://doi.org/10.1002/(SICI)1097-0045(19991201)41:4<263::AID-PROS7>3.0.CO;2-0
- Aryal M, Pandeya A, Bas BK, Lamsal M, Majhi S, Pandit R, et al. 2007. Oxidative stress in patients with benign prostate hyperplasia. JNMA J. Nepal Med. Assoc. 46: 103-106.
- Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkay S, Memis A. 2007. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur. Urol. 51: 199-206. https://doi.org/10.1016/j.eururo.2006.05.040
- Awodele O, Adeyomoye AA, Awodele DF, Fayankinnu VB, Dolapo DC. 2011. Cancer distribution pattern in south-western Nigeria. Tanzan. J. Health Res. 13: 125-131.
- McVARY KT, Rademaker A, Lloyd GL, Gann P. 2005. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J. Urol. 174: 1327-1333. https://doi.org/10.1097/01.ju.0000173072.73702.64
- Isaacs JT, Coffey DS. 1989. Etiology and disease process of benign prostatic hyperplasia. Prostate 15: 33-50. https://doi.org/10.1002/pros.2990150506
- Geller J, Albert J, Lopez D, Geller S, Niwayama G. 1976. Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate. J. Clin. Endocrinol. Metab. 43: 686-688. https://doi.org/10.1210/jcem-43-3-686
- Ho CK, Habib FK. 2011. Estrogen and androgen signaling in the pathogenesis of BPH. Nat. Rev. Urol. 8: 29-41. https://doi.org/10.1038/nrurol.2010.207
- Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B. 2013 Correlation between benign prostatic hyperplasia and inflammation. Curr. Opin. Urol. 23: 5-10. https://doi.org/10.1097/MOU.0b013e32835abd4a
- Wermuth PJ, Del Galdo F, Jimenez SA. 2009. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents. Arthritis Rheum. 60: 1508-1518. https://doi.org/10.1002/art.24471
- Pierce KL, Tohgo A, Ahn S, Field ME, Luttrell LM, Lefkowitz RJ. 2001. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J. Biol. Chem. 276: 23155-23160. https://doi.org/10.1074/jbc.M101303200
- Kerry RG, Patra JK, Gouda S, Park Y, Shin HS, Das G. 2018. Benefaction of probiotics for human health: a review. J. Food Drug Anal. 26: 927-939. https://doi.org/10.1016/j.jfda.2018.01.002
- Wagner R, Pierson C, Warner T, Dohnalek M, Hilty M, Balish E. 2000. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J. Food Prot. 63: 638-644. https://doi.org/10.4315/0362-028X-63.5.638
- Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, Han YW, et al. 2009. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J. Microbiol. 47: 101-109. https://doi.org/10.1007/s12275-008-0179-y
- Choi EJ, Iwasa M, Han KI, Kim WJ, Tang Y, Hwang YJ, et al. 2016. Heat-killed Enterococcus faecalis EF-2001 ameliorates atopic dermatitis in a murine model. Nutrients 8: 146. https://doi.org/10.3390/nu8030146
- Choi EJ, Iwasa M, Han KI, Kim WJ, Tang Y, Han WC, et al. 2016. Effect of Enterococcus faecalis EF-2001 on experimentally induced atopic eczema in mice. Food Sci. Biotechnol. 25: 1087-1093. https://doi.org/10.1007/s10068-016-0175-7
- Chang SJ, Lee MH, Kim WJ, Chae Y, Iwasa M, Han KI, et al. 2019. Effect of heat-killed Enterococcus faecalis, EF-2001 on C2C12 myoblast damage induced by oxidative stress and muscle volume decreased by sciatic denervation in C57BL/6 mice. J. Life Sci. 29: 215-222. https://doi.org/10.5352/JLS.2019.29.2.215
- Choi EJ, Lee HJ, Kim WJ, Han KI, Iwasa M, Kobayashi K, et al. 2019. Enterococcus faecalis EF-2001 protects DNBS-induced inflammatory bowel disease in mice model. PLoS One 14: e0210854. https://doi.org/10.1371/journal.pone.0210854
- Gu YH, Choi H, Yamashita T, Kang KM, Iwasa M, Lee MJ, et al. 2017. Pharmaceutical production of anti-tumor and immunepotentiating Enterococcus faecalis-2001 β-glucans: enhanced activity of macrophage and lymphocytes in tumor-implanted mice. Curr. Pharm. Biotechnol. 18: 653-661.
- Choi YJ, Fan M, Tang Y, Yang HP, Hwang JY, Kim EK. 2019. In vivo effects of polymerized anthocyanin from grape skin on benign prostatic hyperplasia. Nutrients 11: 444. https://doi.org/10.3390/nu11020444
- Ohtake A, Ukai M, Saitoh C, Sonoda R, Noguchi Y, Okutsu H, et al. 2006. Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure. Eur. J. Pharmacol. 545: 185-191. https://doi.org/10.1016/j.ejphar.2006.06.054
- Sheth SG, Flamm SL, Gordon FD, Chopra S. 1998. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 93: 44-48. https://doi.org/10.1111/j.1572-0241.1998.044_c.x
- Soulitzis N, Karyotis I, Delakas D, Spandidos DA. 2006. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int. J. Oncol. 29: 305-314.
- McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, et al. 2007. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta 1773: 1263-1284. https://doi.org/10.1016/j.bbamcr.2006.10.001
- Dietrich DR. 1993. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit. Rev. Toxicol. 23: 77-109. https://doi.org/10.3109/10408449309104075
- Tashiro E, Tsuchiya A, Imoto M. 2007. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 98: 629-635. https://doi.org/10.1111/j.1349-7006.2007.00449.x
- Vela-Navarrete R, Escribano-Burgos M, Farre AL, Garcia-Cardoso J, Manzarbeitia F, Carrasco C. 2005. Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. J. Urol. 173: 507-510. https://doi.org/10.1097/01.ju.0000150533.94952.25
- Dmochowski RR. 2005. Bladder outlet obstruction: etiology and evaluation. Rev. Urol. 7: S3.
- Boyle P, Roehrborn C, Harkaway R, Logie J, de La Rosette J, Emberton M. 2004. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur. Urol. 45: 620-627. https://doi.org/10.1016/j.eururo.2003.09.012
- Nickel JC. 2008. Inflammation and benign prostatic hyperplasia. Urol. Clin. North Am. 35: 109-115. https://doi.org/10.1016/j.ucl.2007.09.012
- Sciarra A, Mariotti G, Salciccia S, Gomez AA, Monti S, Toscano V, et al. 2008. Prostate growth and inflammation. J. Steroid Biochem. Mol. Boil. 108: 254-260. https://doi.org/10.1016/j.jsbmb.2007.09.013
- Chughtai B, Lee R, Te A, Kaplan S. 2011. Role of inflammation in benign prostatic hyperplasia. Rev. Urol. 13: 147.
- Penna G, Mondaini N, Amuchastegui S, Degli Innocenti S, Carini M, Giubilei G, et al. 2007. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur. Urol. 51: 524-533. https://doi.org/10.1016/j.eururo.2006.07.016
- Bechis SK, Otsetov AG, Ge R, Olumi AF. 2014. Personalized medicine for the management of benign prostatic hyperplasia. J. Urol. 192: 16-23. https://doi.org/10.1016/j.juro.2014.01.114
- Youn DH, Park J, Kim HL, Jung Y, Kang J, Jeong MY, et al. 2017. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase. Oncotarget 8: 9500-9512. https://doi.org/10.18632/oncotarget.13430
- Ellem SJ, Risbridger GP. 2009. The dual, opposing roles of estrogen in the prostate. Ann. NY Acad. Sci. 1155: 174-186. https://doi.org/10.1111/j.1749-6632.2009.04360.x
- Lee KL, Peehl DM. 2004. Molecular and cellular pathogenesis of benign prostatic hyperplasia. J. Urol. 172: 1784-1791. https://doi.org/10.1097/01.ju.0000133655.71782.14
- Dejean LM, Martinez-Caballero S, Manon S, Kinnally KW. 2006. Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim. Biophys. Acta 1762: 191-201. https://doi.org/10.1016/j.bbadis.2005.07.002
- Choi MS, Chang SJ, Chae Y, Lee MH, Kim WJ, Iwasa M, et al. 2018. Anti-inflammatory effect of heat-killed Enterococcus faecalis, EF-2001. J. Life Sci. 28: 1361-1368. https://doi.org/10.5352/JLS.2018.28.11.1361